Pharmaceuticals 2011 - FDA's DDMAC Compliance: Current Issues and Emerging Perspectives
Date2011-11-17
Deadline2011-11-17
VenuePalo Alto, USA - United States
KeywordsDDMAC Compliance;DDMAC-01;FDA's DDMAC Requirements;Drug Marketing;Strategic initiatives
- 33rd Global Conference on Advances in Emerging Engineering Technologies (GAEET-25)
- 4th International Conference on Primary Health Care
- 2025 International Conference on Interdisciplinary Perspectives in Social Sciences and Humanities
- The 13th Int'l Conference on Advanced Nanomaterials and Emerging Applications(ANEA 2026)
- Geographic Perspectives on Climate Change Mitigation in Urban and Rural Environments - 2nd Edition
Topics/Call fo Papers
This DDMAC Compliance training will cover regulations, their application and enforcement activities as they relate to FDA’s Division of Drug Marketing, Advertising and Communications.
Why Should You Attend:
This course provides a survey of the regulations, their application and enforcement activities as they relate to FDA’s Division of Drug Marketing, Advertising and Communications. With that background, we will explore current issues in drug product promotion, including web-based activities.
By the end of this webinar, the participant will have a basic understanding of vocabulary and the context by which the Division of Drug Marketing and Advertising (DDMAC) reviews and evaluates information that can be “promotional” in nature. The role of DDMAC has broadened to address the advent of social media and advanced means of communications ? which means there are emerging rules and practices of which a sponsor needs to be aware. This session will address all of the above.
Other CFPs
- 2012 International Conference on Green Buildings and Optimization Design (GBOD 2012)
- Understanding ISO 14644-1: What is Required of Pharmaceutical Manufacturers
- 4th International Congress on Cell Membranes and Oxidative Stress: Focus on Calcium Signaling and TRP Channels
- Water System Mythology: Common False Beliefs for Microbial Control and Monitoring
- Pharmaceutical Deviations Handling
Last modified: 2011-09-29 17:23:12